This is the report. What does it signify and what’s the treatment?

Reading File
Reading File
Reading File
Reading File
Running Command

python3 -c " import pdfplumber with pdfplumber.open('/tmp/workspace/attachments/5f987d73-626f-4a49-9a3a-6df7884008a1/Mrs_ISHIKA_22_F_report.pdf') as pdf: for i, page in enumerate(pdf.pages): print(f'--- Page {i+1} ---') print(page.extract_text()) "

Finding Sources
Finding Sources
Searching PubMed

brain granuloma MRI cortical young adult

Finding Sources
Finding Sources
Searching PubMed

neurocysticercosis granuloma MRI treatment

Finding Sources
Finding Sources
Reading Article

PMID: 41484678

Reading File
Reading File
Loading Image
Searching Images

brain granuloma MRI T2 hypointense cortical parietal peripheral enhancement

This diagnostic imaging composite displays Magnetic Resonance Imaging (MRI) of the brain in three planes: sagittal (a), axial (b), and coronal (c). The images reveal a single, well-defined, rounded ring-enhancing lesion located in the left parietal region. In the T2-weighted axial view (b), the lesion is hyperintense with a hypointense rim and is surrounded by extensive hyperintense signal indicating vasogenic edema, which results in partial effacement of the adjacent cortical sulci and subarachnoid space. Contrast-enhanced sections (a and c) demonstrate moderate, discrete peripheral rim enhancement with a darker central core. Blue arrows in each panel point to the lesion and its associated inflammatory changes. This presentation is characteristic of a neuroinflammatory process or an infectious granuloma, such as neurocysticercosis or a cerebral abscess. The imaging is critical for medical students and clinicians to study intracranial mass effects, the breakdown of the blood-brain barrier, and differential diagnosis of ring-enhancing lesions.

This diagnostic imaging composite displays Magnetic Resonance Imaging (MRI) of the brain in three planes: sagittal (a), axial (b), and coronal (c). The images reveal a single, well-defined, rounded ring-enhancing lesion located in the left parietal region. In the T2-weighted axial view (b), the lesion is hyperintense with a hypointense rim and is surrounded by extensive hyperintense signal indicating vasogenic edema, which results in partial effacement of the adjacent cortical sulci and subarachnoid space. Contrast-enhanced sections (a and c) demonstrate moderate, discrete peripheral rim enhancement with a darker central core. Blue arrows in each panel point to the lesion and its associated inflammatory changes. This presentation is characteristic of a neuroinflammatory process or an infectious granuloma, such as neurocysticercosis or a cerebral abscess. The imaging is critical for medical students and clinicians to study intracranial mass effects, the breakdown of the blood-brain barrier, and differential diagnosis of ring-enhancing lesions.

This diagnostic image consists of two axial MRI slices of the head, labeled A and B, illustrating a prominent osteolytic lesion of the right posterior parietal skull vault. Image A is a T1-weighted sequence showing a heterogeneous, predominantly hypointense lesion measuring 34 x 17 mm in the transverse plane. There is visible peripheral enhancement along the inner table, suggesting dural or pachymeningeal involvement. Image B is a T2-weighted sequence where the lesion appears markedly hyperintense relative to the brain parenchyma. The mass demonstrates full-thickness erosion of the skull vault with focal inward bulging into the epidural space. Notably, there is no evidence of underlying brain parenchymal edema or cortical signal abnormality, indicating the lesion remains extradural without pial passage. These images are characteristic of calvarial tumors or inflammatory processes (such as eosinophilic granuloma or metastatic disease) requiring multiplanar evaluation to assess dural integrity and intracranial extension.

This diagnostic image consists of two axial MRI slices of the head, labeled A and B, illustrating a prominent osteolytic lesion of the right posterior parietal skull vault. Image A is a T1-weighted sequence showing a heterogeneous, predominantly hypointense lesion measuring 34 x 17 mm in the transverse plane. There is visible peripheral enhancement along the inner table, suggesting dural or pachymeningeal involvement. Image B is a T2-weighted sequence where the lesion appears markedly hyperintense relative to the brain parenchyma. The mass demonstrates full-thickness erosion of the skull vault with focal inward bulging into the epidural space. Notably, there is no evidence of underlying brain parenchymal edema or cortical signal abnormality, indicating the lesion remains extradural without pial passage. These images are characteristic of calvarial tumors or inflammatory processes (such as eosinophilic granuloma or metastatic disease) requiring multiplanar evaluation to assess dural integrity and intracranial extension.

This composite diagnostic image displays six axial MRI brain sequences (a-f) of a 27-year-old female, illustrating the neuroradiological features of cortical vein thrombosis in the right postcentral parietal region. Sequence (a) T2-weighted and (b) FLAIR images demonstrate a hyperintense cortical lesion (arrows). The (c) T2*-weighted image reveals significant signal loss and a 'blooming' artifact localized to a central cortical vein, indicative of paramagnetic blood products such as deoxyhemoglobin or hemosiderin within a thrombus. The (d) pre-contrast T1-weighted image shows a subtle isointense to hypointense lesion, while (e) the post-contrast T1-weighted image exhibits circumscribed peripheral enhancement, suggesting blood-brain barrier disruption. Finally, (f) the Diffusion-Weighted Imaging (DWI) shows restricted diffusion (arrow), confirming an acute thrombus. These findings serve as a critical differential diagnostic tool to distinguish cortical vein thrombosis from cortical superficial siderosis (cSS). The presence of the tubular blooming effect and intravasal diffusion restriction are key pedagogical markers for identifying venous outflow disorders in clinical practice.

This composite diagnostic image displays six axial MRI brain sequences (a-f) of a 27-year-old female, illustrating the neuroradiological features of cortical vein thrombosis in the right postcentral parietal region. Sequence (a) T2-weighted and (b) FLAIR images demonstrate a hyperintense cortical lesion (arrows). The (c) T2*-weighted image reveals significant signal loss and a 'blooming' artifact localized to a central cortical vein, indicative of paramagnetic blood products such as deoxyhemoglobin or hemosiderin within a thrombus. The (d) pre-contrast T1-weighted image shows a subtle isointense to hypointense lesion, while (e) the post-contrast T1-weighted image exhibits circumscribed peripheral enhancement, suggesting blood-brain barrier disruption. Finally, (f) the Diffusion-Weighted Imaging (DWI) shows restricted diffusion (arrow), confirming an acute thrombus. These findings serve as a critical differential diagnostic tool to distinguish cortical vein thrombosis from cortical superficial siderosis (cSS). The presence of the tubular blooming effect and intravasal diffusion restriction are key pedagogical markers for identifying venous outflow disorders in clinical practice.

I now have all the information needed for a thorough, well-sourced answer. Here it is:

MRI Report Summary - Mrs. Ishika, 22F

This is a dynamic contrast MRI of the pituitary and brain done on a 1.5 Tesla unit. The report has two distinct findings, each with its own significance and management implications.

Finding 1: Normal Pituitary - No Microadenoma

What it means: The pituitary gland is of normal size (7.2 mm height, mildly concave superior surface), with no hypointense focus and no differentially enhancing lesion on post-contrast imaging. The radiologist has stated: "No imaging evidence of pituitary microadenoma."
The study was ordered for headache, but the mention of prolactin correlation suggests the clinician suspects hyperprolactinemia (common in young women - causing menstrual irregularities, galactorrhea, infertility). The MRI effectively rules out a pituitary adenoma as the cause.
What to do:
  • Check a serum prolactin level (as advised in the report)
  • If prolactin is mildly elevated (< 2-3x upper limit), causes such as medications (antipsychotics, metoclopramide), hypothyroidism, or physiological stress should be excluded
  • If prolactin is significantly elevated and a microadenoma is still suspected clinically despite a negative MRI, a repeat high-resolution study or dedicated pituitary protocol at 3T may be considered
  • If prolactin is normal, the headache has no pituitary origin

Finding 2: Tiny Left Parietal Granulomatous Lesion (The More Important Finding)

Exact description from the report:
"A T2/FLAIR hypointense nodular focus of size 4 x 3 mm along the cortical aspect of the left parietal lobe with subtle adjoining gliosis. On post-contrast T1 FS: subtle peripheral enhancement."
What this pattern means:
A small, T2-hypointense cortical nodule with peripheral contrast enhancement and surrounding gliosis in a 22-year-old from India is a classic imaging signature of a CNS granuloma. The two most common causes in this region are:
FeatureNeurocysticercosis (NCC)Tuberculoma
CauseTaenia solium larvaeMycobacterium tuberculosis
T2 signalHypointense (calcified/colloidal)Hypointense (central)
EnhancementPeripheral ring/nodularRing or nodular
GliosisPresentPresent
SizeUsually small (<2 cm)Variable
Common in IndiaVery commonVery common
A recent prospective study from India (Karre et al., 2026, Neurological Sciences) found that in CNS granuloma cohorts in endemic zones, the mean age was 24.8 years, 96.7% presented with headache, and 63.3% proved to be tuberculomas on biopsy - with substantial MRI overlap between the two conditions.
Below is what neurocysticercosis lesions look like on MRI (from Harrison's Principles of Internal Medicine):
Neurocysticercosis MRI - multiple lesions in various stages
And a left parietal ring-enhancing granuloma similar to this case:
Left parietal ring-enhancing granuloma MRI - axial, sagittal, coronal views

Recommended Workup

The radiologist has advised dedicated contrast MRI of the brain for further evaluation of this lesion. Additional workup should include:
  1. Dedicated CE-MRI Brain with thin sections, DWI, and ideally MR spectroscopy - to characterize the lesion better and look for additional lesions
  2. Serology: NCC serology (ELISA for T. solium antibodies), Mantoux/TST, IGRA (for TB)
  3. Chest X-ray - to look for pulmonary TB
  4. CSF analysis (if clinically indicated) - for cells, protein, ADA, and Gram stain/culture
  5. Ophthalmology review - to rule out ocular cysticercosis or TB

Treatment Approach

Treatment depends on the final diagnosis, which requires the above workup:

If Neurocysticercosis (single lesion, parenchymal):

  • Albendazole 15 mg/kg/day (max 800 mg/day) for 8-28 days - monotherapy for 1-2 cysts
  • Dexamethasone 0.1-0.4 mg/kg/day or prednisone 60 mg/day concurrently - mandatory to prevent inflammatory flare
  • Anti-seizure medication if seizures occur (can be tapered at 6 months if lesion resolves and patient is seizure-free)
  • Antiparasitic treatment is never an emergency - stabilize the patient first
  • (Bradley and Daroff's Neurology in Clinical Practice, Treatment Table 79.7)

If Tuberculoma:

  • Standard anti-tuberculous therapy (ATT): HRZE for 2 months, then HR for 7-10 months (total 9-12 months for CNS TB)
  • Corticosteroids (dexamethasone) to reduce inflammation, especially if edema is significant
  • Serial MRI monitoring for response

If the lesion is calcified (no active enhancement on dedicated MRI):

  • No antiparasitic treatment is needed
  • Treat symptoms (anti-seizure drugs if seizures occur)

Summary for the Patient

What it means
Pituitary: NormalNo adenoma found; check serum prolactin blood test
Left parietal lesionSmall 4x3 mm granuloma - likely a parasite (tapeworm cyst) or TB focus
Urgent next stepDedicated brain MRI + blood/CSF tests to confirm which one
TreatmentAnthelmintic or anti-TB drugs + steroids, depending on diagnosis
This is a benign, treatable condition in all likelihood, but the cause must be confirmed before starting treatment. Mrs. Ishika should be referred to a neurologist or infectious disease specialist promptly.
This is a shared conversation. Sign in to Orris to start your own chat.